SCHEMBL24815703

SCHEMBL24815703

O=C(CS(=O)(=O)c1ccc(F)cn1)N1Cc2ccccc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.41
▸ CXCR2 P25025 1/20 0.40
▸ RIPK1 Q13546 1/20 0.38
▸ LMNA P02545 3/20 0.38
▸ POLB P06746 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.38
▸ TAS1R1 Q7RTX1 1/20 0.38
▸ TAS1R2 Q8TE23 1/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ RAB9A P51151 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ NOTUM Q6P988 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986911 1.00 NAMPT (0.43) NAMPTL3MBTL1ALDH1A1CXCR2RIPK1
SCHEMBL24815671 0.81 ALDH1A1 (0.44) NAMPTALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL29986504 0.81 ALDH1A1 (0.44) NAMPTALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL29987274 0.81 NAMPT (0.46) NAMPT
SCHEMBL24814393 0.81 NAMPT (0.46) NAMPT
SCHEMBL24817130 0.80 SMN1; SMN2 (0.52) NAMPTL3MBTL1ALDH1A1POLBSMN1; SMN2
SCHEMBL29986546 0.80 SMN1; SMN2 (0.52) NAMPTL3MBTL1ALDH1A1POLBSMN1; SMN2
SCHEMBL24816196 0.78 TAS1R3 (0.50) L3MBTL1ALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL24815895 0.78 ALDH1A1 (0.41) NAMPTL3MBTL1ALDH1A1LMNAPOLB
SCHEMBL29986069 0.78 TAS1R3 (0.50) L3MBTL1ALDH1A1LMNAPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH NAMPT 2850/4885L3MBTL1 509/4885ALDH1A1 3533/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH NAMPT 2850/4885L3MBTL1 509/4885ALDH1A1 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback